- Article
- Source: Campus Sanofi
- 23 Oct 2023
Academy of Knowledge MS Scientific Exchange Forum
Professor Jiwon Oh
MD, PhD
St. Michael's Hospital, University of Toronto, Canada
Professor Gavin Giovannoni
MBBCh, PhD, FCP, FRCP, FRCPath
Barts and the London School of Medicine and Dentistry, UK
Professor Patrick Vermersch
MD, PhD
University of Lille, France
Professor Jiwon Oh
MD, PhD
St. Michael's Hospital, University of Toronto, Canada
Professor Gavin Giovannoni
MBBCh, PhD, FCP, FRCP, FRCPath
Barts and the London School of Medicine and Dentistry, UK
Professor Patrick Vermersch
MD, PhD
University of Lille, France
Watch now a selection of these talks covering brain health, smouldering disease and the clinical use of AUBAGIO® (teriflunomide). |
Reflective learning guides are available to download to track your progress and for the opportunity of CPD certification. |
Prescribing Information can be found through the links in the Product Cards at the bottom of the page.
Preserving Brain Health
Preserving Brain Health | Part 1: Underlying Pathology of Chronic Smouldering MS - Prof. Gavin Giovannoni
Preserving Brain Health | Part 2: Clinical Progression and Smouldering Disease - Prof. Gavin Giovannoni
Preserving Brain Health | Part 3: Advanced Imaging Techniques in Routine Clinical Practice - Prof. Jiwon Oh
Preserving Brain Health | Part 1: Underlying Pathology of Chronic Smouldering MS - Prof. Gavin Giovannoni
Preserving Brain Health | Part 2: Clinical Progression and Smouldering Disease - Prof. Gavin Giovannoni
Preserving Brain Health | Part 3: Advanced Imaging Techniques in Routine Clinical Practice - Prof. Jiwon Oh
Aubagio Overviews
AUBAGIO® (teriflunomide): MoA and Safety - Prof. Patrick Vermersch
AUBAGIO® (teriflunomide) Overview: Efficacy (Brain Health) and Real-World (Patient-Reported Outcomes, Adherence, Effectiveness) - Prof. Jiwon Oh
AUBAGIO® (teriflunomide): MoA and Safety - Prof. Patrick Vermersch
AUBAGIO® (teriflunomide) Overview: Efficacy (Brain Health) and Real-World (Patient-Reported Outcomes, Adherence, Effectiveness) - Prof. Jiwon Oh
Neurology Products
Prescribing Information GB MAT-XU-2200676 (v6.0) |
Prescribing Information GB MAT-XU-2200680 (v3.0) |
MAT-GB-2200916 (v4.0) Date of preparation: October 2023